Association of thyroid diseases with primary extra-thyroidal malignancies in women: Results of a cross-sectional study of 6,386 patients

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Prinzi, Natalie ^a   Sorrenti, Salvatore ^b   Baldini, Enke ^a   De Vito, Corrado ^c   Tuccilli, Chiara ^a   Catania, Antonio ^b   Coccaro, Carmela ^a   Bianchini, Marta ^a   Nesca, Angela ^a   Grani, Giorgio ^a   Mocini, Renzo ^b   De Antoni, Enrico ^b   D'Armiento, Massimino ^a   Ulisse, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; AUTOANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNITY; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MELANOMA; OVARY CANCER; PATIENT CODING; PREVALENCE; PRIMARY TUMOR; THYROID DISEASE; THYROID NODULE; UTERUS CANCER; ADOLESCENT; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; NEOPLASM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS; THYROID DISEASES; YOUNG ADULT;

EID: 84926615254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122958     Document Type: Article

References (44)

1. Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011; 99: 39-51. doi: 10.1093/bmb/ldr030 PMID: 21893493
2. Gharib M, Gharib H. Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int. 2011; 1: 3-11. doi: 10.1186/1687-9856-2011-3 PMID: 21860630
3. Mehanna HM, Jain A, Morton RP, Watkinson J, Shaha A. Investigating the thyroid nodule. BMJ 2009; 338: b733. doi: 10.1136/bmj.b733 PMID: 19286747
4. Trimboli P, Ulisse S, Graziano FM, Marzullo A, Ruggieri M, Calvanese A, et al. Trend in thyroid carcinoma size, age at diagnosis and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid 2006; 16: 1151-1155. PMID: 17123342
5. Danese D, Centanni M, Farsetti A, Andreoli M (1997) Diagnosis of thyroid carcinoma. J Exp Clin Cancer Res 1997; 16: 337-347. PMID: 9387911
6. Pisani T, Pantellini F, Centanni M, Vecchione A, Giovagnoli MR. Immunocytochenical expression of Ki67 and laminin in Hurtle cell adenoma and carcinomas. Anticancer Res. 2003; 23: 3323-3326. PMID: 12926070
7. Paschke R. Molecular pathogenesis of nodular goiter. Langenbecks Arch Surg. 2011; 396: 1127-1136. doi: 10.1007/s00423-011-0788-5 PMID: 21487943
8. Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Wolters Kluwer-Lippincott Williams & Wilkins; 2009.
9. Bonora E, Tallini G, Romeo G. Genetic predisposition to familial nonmedullary thyroid cancer: an update of molecular findings and state-of-art studies. J Oncol. 2010; 2010: 385206. doi: 10.1155/2010/385206 PMID: 20628519
10. Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol. 2012; 19: 1887-1896. doi: 10.1245/s10434-011-2193-2 PMID: 22227921
11. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, et al. Risk of thyroid cancer in survivors of childhood cancer: results from the british childhood cancer survivor study. Int J Cancer 2009; 125: 2400-2405. doi: 10.1002/ijc.24581 PMID: 19610069
12. Bhatti P, Veiga LHS, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 2010; 174: 741-752. doi: 10.1667/RR2240.1 PMID: 21128798
13. Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010; 174: 840-850. doi: 10.1667/RR1903.1 PMID: 21128808
14. Canchola AJ, Horn-Ross PL, Purdie DM. Risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol. 2006; 163: 521-527. PMID: 16421240
15. Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, et al. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 2009; 19: 451-457. doi: 10.1089/thy.2008.0392 PMID: 19281429
16. Brown AP, Chen J, Hitchcock YI, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancy up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008; 93: 504-515. PMID: 18029468
17. Berthe E, Henty-Amar M, Michels JJ, Rame JP, Berthet P, Babin E, et al. Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2004; 31: 685-691. PMID: 14747959
18. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, et al. Second primary malignancies in thyroid cancer patients. Br J Cancer 2003; 89: 1638-1644. PMID: 14583762
19. Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Hibraim-Zada I, et al. Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid 2007; 17: 1277-1288. PMID: 18020916
20. Ronckers CM, McCarron P, Ron E. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 2005; 117: 281-288. PMID: 15880372
21. Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, et al. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett. 2006; 238: 42-52. PMID: 16039041
22. Sandeep TC, Strachan MWJ, Reynolds RM, Brewster DH, Scélo G, Pukkala E, et al. Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab. 2006; 91: 1819-1825. PMID: 16478820
23. Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat. 2012; 133: 1169-1177. doi: 10.1007/s10549-012-2019-3 PMID: 22434524
24. Sarlis N, Gourgiotis L, Pucino F, Tollis G. Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones 2002; 1: 35-41. PMID: 17018436
25. Prinzi N, Baldini E, Sorrenti S, De Vito C, Tuccilli C, Catania A, et al. Prevalence of breast cancer in thyroid diseases: results of a cross-sectional study of 3,921 patients. Breast Cancer Res Treat. 2014; 144: 683-688. doi: 10.1007/s10549-014-2893-y PMID: 24604093
26. Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, et al. Cancer risk in patients with Graves' disease: a nationwide cohort study. Thyroid 2013; 23: 879-84. doi: 10.1089/thy.2012.0568 PMID: 23421548
27. Chen YK, Lin CL, Cheng FT, Sung FC, Kao CH. Cancer risk in patients with Hashimoto's thyroiditis: a natiowide cohort study. Br J Cancer 2013; 109: 2496-2501. doi: 10.1038/bjc.2013.597 PMID: 24084773
28. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012; 18: 988-1028. PMID: 23246686
29. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and American association of clinical endocrinologists. Thyroid 2011; 21: 593-646. doi: 10.1089/thy.2010.0417 PMID: 21510801
30. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214. doi: 10.1089/thy.2009.0110 PMID: 19860577
31. Aghini-Lombardi F, Antonangeli L, Vitti P, Pinchera A. Status of iodine nutrition in Italy. In: Delange F, Dunn JT & Glinoer D, editors. Iodine Deficiency in Europe. A Continuing Concern. New York: Plenum Press; 1993. Pp. 403-408.
32. AIRTUM Working Group. Italian cancer figures, report 2010: cancer prevalence in Italy. Patients living with cancer, long term survivors and cured patients. Epidemiol Prev. 2010; 34: 1-188. PMID: 21220828
33. De Remigis A, de Gruijl TD, Uram JN, Tzou SC, Iwama S, Talor MV, et al. Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival. Int J Cancer 2014; 136: 127-137. doi: 10.1002/ijc.28973 PMID: 24832153
34. Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF, et al. Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metabol. 1998; 83: 2711-2716. PMID: 9709936
35. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk in patients hospitalized for Graves' disease: a population-based cohort study in Sweden. Br J Cancer 2010; 102: 1397-1399. doi: 10.1038/sj.bjc.6605624 PMID: 20354521
36. Silva JM, Domínguez G, González-Sancho JM, García JM, Silva J, Garcia-Andrade C, et al. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 2002; 21: 4307-4316. PMID: 12082618
37. Nogueira CR, Brentani MM. Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 1996; 59: 271-279. PMID: 9010319
38. Ulisse S, Tata JR. Thyroid hormone and glucocorticoid independently regulate the expression of estrogen receptor in male Xenopus liver cells. Mol Cell Endocrinol. 1994; 105: 45-53. PMID: 7821717
39. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 2005; 103: 1122-1128. PMID: 15712375
40. Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C, et al. Thyroid function in breast cancer patients. Anticancer Res 2010; 30: 1713-1717. PMID: 20592366
41. Cecconi S, Rucci N, Scaldaferri ML, Masciulli MP, Rossi G, Moretti C, et al. Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity. Endocrinology 1999; 140: 1783-1788. PMID: 10098516
42. Ulisse S, Jannini EA, Carosa E, Piersanti D, Graziano FM, D'Armiento M. Inhibition of aromatase activity in rat Sertoli cells by thyroid hormone. J Endocrinol. 1994; 140: 431-436. PMID: 8182371
43. Kuijpens JL, Nyklíctek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 2005; 15: 1253-1259. PMID: 16356089
44. Sandhu MK, Brezden-Masley C, Lipscombe LL, Zagorski B, Booth GL. Autoimmune hypothyroidism and breast cancer in the elderly. Breast Cancer Res Treat 2009; 115: 635-641. doi: 10.1007/s10549-008-0104-4 PMID: 18604583